Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
modified Ma Xing Shi Gan Decoction
Universal Integrated
Chronic Obstructive Pulmonary Disease
1 trial -
multi-factorial intervention
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
multi-vitamin carbohydrate
The First People's Hospital of Lianyungang
Nausea and Vomiting, Aspiration, Intraoperative
1 trial -
naloxone nasal spray kit
BRIGHT MINDS BIOSCIENCES INC.
Drug Overdose
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
oxycodone and parecoxib sodium combinations
The First People's Hospital of Lianyungang
Oxycodone
1 trial -
pancrelipase with bicarbonate
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Pain, Postoperative
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial -
placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
PCOS- Polycystic Ovary Syndrome
1 trial -
placebo
CUMBERLAND PHARMACEUTICALS INC
Autism
1 trial -
placebo (compared to vasoconstrictor)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Male
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
IBD (Inflammatory Bowel Disease)
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
Colonoscopy: Bowel Preparation
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotic cocktail capsules
Hospital Authority, Hong Kong
Vancomycin-Resistant Enterococci
1 trial -
probiotics
Hospital Authority, Hong Kong
Parkinson's Disease (PD)
1 trial -
probiotics
The First People's Hospital of Lianyungang
Ulcerative Colitis
1 trial -
probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Necrotizing Enterocolitis
1 trial -
prochlorperazine and benadryl IV
United Therapeutics Europe Ltd
Acute Migraine Headache
1 trial -
pure give pectin 20g/d for five days
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Inflammatory Bowel Disease
1 trial -
rabeprazole plus aspirin versus rabeprazole plus clopidogrel
Hospital Authority, Hong Kong
Gastric Ulcer
1 trial -
remimazolam combined with remifentanil
The First People's Hospital of Lianyungang
Difficult or Failed Intubation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources